Status:
COMPLETED
NIV-Training in Hypercapnic COPD Patients
Lead Sponsor:
Schön Klinik Berchtesgadener Land
Collaborating Sponsors:
Löwenstein Medical GmbH & Co. KG
Bad Reichenhaller Forschungsanstalt
Conditions:
COPD
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The aim of the study is to investigate the additional effects of the use of NIV during exercise within a 3-week PR program on exercise capacity in COPD patients with chronic hypercapnic respiratory fa...
Detailed Description
Scientific Background/ Rationale: Quality of life and exercise tolerance are commonly reduced in people with chronic obstructive pulmonary disease (COPD), especially in people with chronic hypercapni...
Eligibility Criteria
Inclusion
- Diagnosis of very severe COPD Gold Stage IV
- Age: 40-80 years
- PaCO2 \>50mmHg (at rest, during sleep or exercise)
- Implemented nocturnal non-invasive ventilation therapy
Exclusion
- Concomitant cardiovascular, orthopaedic or neurological conditions that are likely to be the primary impairment to exercise performance
- Other significant pulmonary disease which could affect exercise or NIV (e.g. asthma)
- BMI \> 35 kg/m2
- Inability to give informed consent
Key Trial Info
Start Date :
January 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03803358
Start Date
January 7 2019
End Date
July 27 2021
Last Update
July 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schoen Klinik Berchtesgadener Land
Schönau am Königssee, Bavaria, Germany, 83471